Neurocrine Biosciences
NBIX
#1395
Rank
NZ$21.79 B
Marketcap
$215.25
Share price
0.52%
Change (1 day)
16.79%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company